Baldino

Brian J. Baldino, Milpitas, CA US

Patent application number	Description	Published
20100302345	System and Method for Extending Communications Between Participants in a Conferencing Environment - A method is provided in one example embodiment and includes receiving data associated with a local endpoint that is configured to participate in a video conference. The local endpoint can be configured to detect a signal generated by a local end user device and to relay the signal to a local manager element. The method also includes transmitting the signal over a network to a remote manager element at a remote location. In more specific embodiments, the method includes receiving an additional signal from the remote manager element, and determining a selected local endpoint to receive the additional signal from the remote manager element.	12-02-2010

Patent application number	Description	Published
20080266379	Method and system for optimal balance and spatial consistency - A method for assigning video signals includes receiving a plurality of video signals from a plurality of cameras located at one or more remote sites, the plurality of video signals for display on a plurality of monitors at a local site. The method also includes determining an optimal monitor for displaying a first video signal associated with a first camera based on the location and alignment of the first camera in relation to one or more of the plurality of cameras. In addition, the method includes calculating a respective difference between a number of video signals assigned to the optimal monitor and a respective number of video signals assigned to each respective monitor of the plurality of monitors. The method further includes assigning the first video signal to the optimal monitor if the respective difference is not greater than a threshold value with respect to each of the plurality of monitors.	10-30-2008

Patent application number	Description	Published
20110046362	METHODS OF MAKING NUCLEOSIDE TETRAPHOSPHATE - The invention provides compounds and methods for making adenosine-ribofuranoside tetraphosphate compounds. The compounds are contemplated to have activity at the P2Y receptor and may be used in the treatment of medical disorders such as cystic fibrosis and upper respiratory disorders.	02-24-2011
20110152235	Aminopyrimidine Kinase Inhibitors - Disclosed are compounds, pharmaceutical compositions containing those compounds, and uses of the compounds and compositions as modulators of casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), Pim 1, Pim2, Pim3, the TGFβ pathway, the Wnt pathway, the JAK/STAT pathway, and/or the mTOR pathway. Uses are also disclosed for the treatment or prevention of a range of therapeutic indications due at least in part to aberrant physiological activity of casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), Pim 1, Pim2, Pim3, the TGFβ pathway, the Wnt pathway, the JAK/STAT pathway, and/or the mTOR pathway.	06-23-2011